ArticleTherapeutic advances in medical oncology2023

The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models.

Gwo Yaw Ho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.